SEI Investments
TNXP icon

SEI Investments’s Tonix Pharmaceuticals TNXP Stock Holding History

SEI Investments’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$465K Buy
36,472
+25,501
+232% +$329K ﹤0.01% 2672
2026
Q1 		$151K Hold
10,971
– – ﹤0.01% 3021
2025
Q4 		$171K Buy
+10,971
New +$202K ﹤0.01% 2937

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SEI Investments's TNXP Position: Q2 2026 in Review

SEI Investments increased its Tonix Pharmaceuticals (TNXP) stake by 232% in Q2 2026, buying an estimated $329K and bringing the position to 36,472 shares worth $465K. The position accounts for ﹤0.01% of the portfolio, ranked #2672.

SEI Investments first reported a position in TNXP in Q4 2025 and has held it in 3 quarters since. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • SEI Investments held 36,472 shares of Tonix Pharmaceuticals worth $465K as of Q2 2026.
  • SEI Investments bought 25,501 Tonix Pharmaceuticals shares in Q2 2026, an estimated $329K.
  • Tonix Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2672 holding.
  • SEI Investments first reported a position in Tonix Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.